Newsletter December 2020
Follow our News
We propose a condensate of ImaBiotech news and released information on a quarterly based. We are proud to be an active contract research organization that develops technologies and push the boundaries to create more effective platforms to support safer and better therapies.
In this edition, we share exciting news about the company expansion of unique services to leverage drug development effort. With the introduction of a comprehensive image-based multi-omics platform ‘ImaLink’, ImaBiotech is now providing a unique offer to deliver the full picture from the drug activity to the patient response.
In this edition, you will also discover the testing panel capabilities now offered though ‘ImaLink’, the latest single cell imaging capability, and finally an interview with the Founder and CEO of Imabiotech, Dr. Jonathan Stauber on the importance of multi-modalities spatialomics in drug development.
Discover our Videos on Youtube/ImaBiotech